Nuclear Medicine Imaging of Pheochromocytoma and Neuroblastoma

Overview

Journal Q J Nucl Med

Publisher Minerva Medica

Specialty Nuclear Medicine

Date 1999 Nov 24

PMID 10568137

Citations 26

Authors

J C Sisson

B L Shulkin

Affiliations

Soon will be listed here.

Abstract

Both pheochromocytomas and neuroblastomas can now be identified and located with a high level of accuracy. Scintigraphy with MIBG has become an indispensable diagnostic method for defining the extent and location of many if not most pheochromocytomas. To define the stage, to document the course and to evaluate the response to therapies in patients with neuroblastoma, imaging with MIBG is now essential.

Citing Articles

Evaluating the diagnostic efficacy of whole-body MRI versus I-mIBG/I-mIBG imaging in metastatic pheochromocytoma and paraganglioma.

Mori H, Wakabayashi H, Saito S, Nakajima K, Yoshida K, Hiromasa T Sci Rep. 2024; 14(1):13828.

PMID: 38879654 PMC: 11180102. DOI: 10.1038/s41598-024-64607-2.

Ga-DOTATATE PET/CT Compared with I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors.

Shahrokhi P, Emami-Ardekani A, Harsini S, Eftekhari M, Fard-Esfahani A, Fallahi B Asia Ocean J Nucl Med Biol. 2020; 8(1):8-17.

PMID: 32064278 PMC: 6994775. DOI: 10.22038/aojnmb.2019.41343.1280.

Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[F]Fluorobenzylguanidine: Biodistribution and Radiation Dosimetry.

Lokitz S, Garg S, Nazih R, Garg P Mol Imaging Biol. 2018; 21(4):686-695.

PMID: 30250991 DOI: 10.1007/s11307-018-1280-1.

Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease.

Kroiss A Wien Med Wochenschr. 2018; 169(1-2):25-32.

PMID: 30182289 DOI: 10.1007/s10354-018-0658-7.

MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies.

Agrawal A, Rangarajan V, Shah S, Puranik A, Purandare N Br J Radiol. 2018; 91(1091):20180103.

PMID: 30048149 PMC: 6475939. DOI: 10.1259/bjr.20180103.